|
業務類別
|
Medical Devices |
|
業務概覽
|
SINTX Technologies Inc is a biomaterials company that develops, manufactures, and commercializes patented and proprietary silicon nitride ceramic biomaterials, composites, devices, and related ceramics technologies for other medical and specialized industrial applications. SINTX has 20 years' experience innovating silicon nitride technologies and operates under a quality management system certified to ISO 13485:2016 and AS9100D, with a product portfolio that includes insulators for Tier 1 aerospace suppliers, the FDA-cleared SiNAPTIC Foot & Ankle Osteotomy Wedge System for reconstructive surgery, OEM manufacturing of FDA-cleared spinal implants, and its SiNERGY technology platform being developed for biocomposite and 3D printing applications. |
| 公司地址
| 1885 West 2100 South, Salt Lake City, UT, USA, 84119 |
| 電話號碼
| +1 801 839-3500 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.sintx.com |
| 員工數量
| 32 |
| Mr. Gregg R. Honigblum |
Chief Investment Officer and Director |
美元 321.44K |
30/10/2026 |
| Mr. Kevin Trask |
Chief Financial Officer |
美元 169.23K |
30/10/2026 |
| Mr. Robert Ryan Elmore |
Chairman of the Board and Chief Executive Officer |
-- |
18/02/2026 |
|
|
| Mr. Jay M. Moyes |
Independent Director |
30/10/2026 |
| Mr. Robert D. Mitchell |
Independent Director |
30/10/2026 |
| Mr. Gregg R. Honigblum |
Chief Investment Officer and Director |
30/10/2026 |
| Mr. Mark Anderson |
Independent Director |
30/10/2026 |
| Mr. Christopher Michael Lyons |
Independent Director |
30/10/2026 |
| Mr. Robert Ryan Elmore |
Chairman of the Board and Chief Executive Officer |
18/02/2026 |
|
|
|
|